NJ Judge Deals Blow To Ongoing IRA Litigation Efforts, Rules In Gov’t Favor

A New Jersey district court on Monday (April 29) rejected separate cases filed by Johnson & Johnson and Bristol Myers Squibb that alleged the Inflation Reduction Act’s Medicare drug price negotiation authority violates the Constitution’s free speech and takings clauses, marking the third and fourth cases in which a federal court has sided with the government over drug makers and industry. The ruling leaves only five cases left awaiting oral arguments or a decision from courts across the country that...